McCannel
 C, Holland
 GN, Helm
 CJ.
 et al.  Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol. 1996;12135- 46
Roberts
 T, Frenkel
 JK. Estimating income losses and other preventable costs caused by toxoplasmosis in people in the United States. J Am Vet Med Assoc. 1990;196249- 256
Roberts
 T, Murrell
 KD, Marks
 S. Economic losses caused by foodborne parasitic diseases. Parasitol Today. 1994;10419- 423
Wilson
 CB, Remington
 JS. What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol. 1980;138357- 363
Couvreur
 J, Desmonts
 G, Tournier
 G, Szuterkac
 M. A homogeneous series of 210 cases of congenital toxoplasmosis in 0 to 11-month-old infants detected prospectively. Ann Pediatr (Paris). 1984;31815- 819
McAuley
 J, Boyer
 KM, Patel
 D.
 et al.  Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994;1838- 72
Koppe
 JG, LoewerSieger
 DH, De
 RH. Results of 20-year follow-up of congenital toxoplasmosis. Lancet. 1986;1254- 256
Mets
 MB, Holfels
 E, Boyer
 KM.
 et al.  Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1996;122309- 324
Wilder
 HC. Toxoplasma chorioretinitis in adults. Arch Ophthalmol. 1952;48127- 136
Zimmerman
 LE. Ocular pathology of toxoplasmosis. Surv Ophthalmol. 1961;6832- 838
Rao
 NA, Font
 RL. Toxoplasmic retinochoroiditis. Arch Ophthalmol. 1977;95273- 277
Hogan
 MJ. Ocular Toxoplasmosis. New York, NY Columbia University Press1951;
Brézin
 AP, Kasner
 L, Thulliez
 P.
 et al.  Ocular toxoplasmosis in the fetus: immunohistochemistry analysis and DNA amplification. Retina. 1994;1419- 26
Hohlfeld
 P, Daffos
 F, Costa
 J-M, Thulliez
 P, Forestier
 F, Cox Vidaud
 M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. N Engl J Med. 1994;331695- 699
Frenkel
 JK, Friedlander
 S. Pathology of Neonatal Disease. Pathogenesis, Diagnosis, and Treatment. Washington, DC US Dept of Public Health1951;Public Health Service publication 141
Remington
 JS, McLeod
 R, Desmonts
 G,  Toxoplasmosis. Remington
 JS, Klein
 JO.edsInfectious Diseases of the Fetus and Newborn. 4th Philadelphia, Pa WB Saunders1995;140- 263
Sibley
 LD, Boothroyd
 JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature. 1992;35982- 85
Holland
 GN. Ocular toxoplasmosis in the immunocompromised host. Int Ophthalmol. 1989;13399- 402
Guerina
 NG, Hsu
 HW, Meissner
 HC.
 et al.  Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med. 1994;3301858- 1863
Fulton
 AB, Craft
 JL, Howard
 RO, Albert
 DM. Human retinal dysplasia. Am J Ophthalmol. 1978;85690- 698
Godel
 V, Nemet
 P, Lazar
 M. Retinal dysplasia. Doc Ophthalmol. 1981;51277- 288
Khalifa
 MA, Rodrigues
 MM, Rajagopalan
 S, Swoveland
 P. Eye pathology associated with measles encephalitis in hamsters. Arch Virol. 1991;119165- 173
Albert
 DM, Lahav
 M, Colby
 ED, Shadduck
 JA, Sang
 DN. Retinal neoplasia and dysplasia, I: induction by feline leukemia virus. Invest Ophthalmol Vis Sci. 1977;16325- 337
Albert
 DM, Lahav
 M, Carmichael
 LE, Percy
 DH. Canine herpes-induced retinal dysplasia and associated ocular anomalies. Invest Ophthalmol. 1976;15267- 278
Parhad
 IM, Johnson
 KP, Wolinsky
 JS, Swoveland
 P. Measles retinopathy: a hamster model of acute and chronic lesions. Lab Invest. 1980;4352- 60
Steinberg
 RH. Interactions between the retinal pigment epithelium and the neural retina. Doc Ophthalmol. 1985;60327- 346
Tanihara
 H, Inatani
 M, Honda
 Y. Growth factors and their receptors in the retina and pigment epithelium. Prog Retinal Eye Res. 1997;16271- 301
Yuodelis
 CA, Hendrickson
 A. Qualitative and quantitative analysis of the human fovea during development. Vision Res. 1986;26847- 855
Perkins
 ES. Ocular toxoplasmosis. Br J Ophthalmol. 1973;571- 17
Holland
 GN, O'Connor
 GR, Belfort
 JR, Remington
 JS,  Toxoplasmosis. Pepose
 JS, Holland
 GN, Wilhelmus
 KR.edsOcular Infection and Immunity St Louis, Mo Mosby1996;1183- 1223
Holland
 GN, Engstrom
 RE
 Jr, Glasgow
 BJ.
 et al.  Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;106653- 667
Manshot
 WA, Daamen
 CBF. Connatal ocular toxoplasmosis. Arch Ophthalmol. 1965;7449- 51
Subauste
 CS, Remington
 JS. Immunity to Toxoplasma gondii. Curr Opin Immunol. 1993;5532- 537
Subauste
 CJS. Role of gamma interferon in Toxoplasma gondii infection. Eur J Clin Microbiol Infect Dis. 1991;1058- 67
George
 JF
 Jr, Schroeder
 HW
 Jr. Developmental regulation old beta reading frame and junctional diversity in T cell receptor-beta transcripts from human thymus. J Immunol. 1992;1481230- 1239
McLeod
 R, Mack
 DG, Boyer
 K.
 et al.  Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med. 1990;116623- 635
Gazzinelli
 RT, Brézin
 A, Li
 Q, Nussenblatt
 RB, Chan
 CC. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp Parasitol. 1994;78217- 229
McMenamin
 PG, Dutton
 GN, Hay
 J, Cameron
 S. The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis, part I: the localization and morphology of toxoplasma cysts in the retina. Exp Eye Res. 1986;43529- 543
Bohne
 W, Heesemann
 J, Gross
 U. Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun. 1993;611141- 1145
Hohlfeld
 P, Daffos
 F, Thulliez
 P.
 et al.  Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989;115765- 769
Berrebi
 A, Kobuch
 WE, Bessieres
 MH.
 et al.  Termination of pregnancy for maternal toxoplasmosis. Lancet. 1994;34436- 39